Publikationen in Zusammenarbeit mit Forschern von French Institute of Health and Medical Research (9)

2020

  1. Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma

    PLoS ONE, Vol. 15, Núm. 9 September

2019

  1. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process

    BMC Cancer, Vol. 19, Núm. 1

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2013

  1. ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo

    Gene, Vol. 521, Núm. 1, pp. 55-61

  2. FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo

    PLoS ONE, Vol. 8, Núm. 1

  3. Zinc chelation: A metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance

    Cell Death and Disease, Vol. 4, Núm. 10

2012

  1. Detectable clonal mosaicism and its relationship to aging and cancer

    Nature Genetics, Vol. 44, Núm. 6, pp. 651-658

2011

  1. CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis

    Journal of Bone and Mineral Research, Vol. 26, Núm. 7, pp. 1533-1542